SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-20-014052
Filing Date
2020-06-17
Accepted
2020-06-17 16:06:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 nt10012477x5_424b3.htm 424B3 132190
2 logo_cidara.jpg GRAPHIC 55201
  Complete submission text file 0001140361-20-014052.txt   209165
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-238955 | Film No.: 20969786
SIC: 2836 Biological Products, (No Diagnostic Substances)